Wednesday, 15 May 2013

Mircera

Mircera

Mircera

Mircera
Mircera


Mircera

Mircera

Generic name/Active ingredient: Methoxy polyethylene glycol-epoetin beta 50/75/100 mcg/ 0.3 ml
Trade name: Mircera
Dosage form: Injection
Drug classification: Erythropoetin Receptor Activator
Legal classification: POM
Company: Roche
Commonly used for: Treatment of serious anemia secondary to Chronic Kidney Disease